YourBio Health Adds Wendy Lane and Christine Heenan to Board of Directors

MEDFORD, Mass., March 18, 2025 – YourBio Health, a pioneer in blood collection technology, today announced the expansion of its Board of Directors with the addition of two esteemed executives: Wendy Lane, a highly experienced corporate director who previously served on the board of Lab Corp for 18 years; and Christine Heenan, Executive Partner, Executive Operations at Flagship Pioneering. The appointments coincide with recent leadership team appointments as the company embarks on a new phase of growth in the application of its TAP® device technology in clinical, diagnostic, and reference laboratory settings.

“Wendy’s extensive strategic, operational, and financial experience, coupled with her deep understanding of the friction points in blood collection, testing, and medical technology will be instrumental in advancing our mission,” said Ignacio Martinez, Chairman of YourBio and General Partner at Flagship Pioneering. “With Christine, we will benefit from her cross-disciplinary experience and perspective as we extend our relationships with regulators, policy makers, and industry partners to meaningfully improve patient care by making blood collection more accessible and convenient for all.”

Lane has more than 30 years of board experience overseeing strategic, operational, and financial changes in public and private companies, as well as extensive experience in health care products and services. She currently sits on the board of Masimo, which offers noninvasive patient monitoring products and analytics. Previously, she served on the board of directors of Realm IDX, which offered integrated diagnostics and imaging; LabCorp, WTW, a major insurance brokerage and advisory company; CoreLogic, a property data and analytics company; MSCI, a provider of financial indexes, index products, and portfolio management tools; and on the boards of nine other companies, some based internationally.

Lane remarked, “YourBio’s TAP® device technology opens up exciting possibilities to greatly improve patient and related family experiences by virtually eliminating pain and fear of blood draws—ideal for young patients or those who need frequent draws. With its seamless integration of the TAP device into existing patient care workflows, YourBio is positioned to make a transformative impact on the industry. I am eager to contribute my expertise to the leadership team as they pursue this promising phase of growth.”

Heenan has made a lasting impact in the worlds of government, academia, communications, and philanthropy. Her career includes serving as Vice President of Public Affairs and Communications at Harvard University and as Senior Vice President for Global Policy & Advocacy at The Rockefeller Foundation. As a Senior Policy Analyst and speechwriter in the White House during the Clinton Administration, her main areas of focus were health care policy, women’s issues, and other areas of domestic policy. Today, she holds the position of Executive Partner at Flagship Pioneering, where she leads executive operations, advising the CEO and senior team on key strategic areas from operations to talent strategy to budget, and helps set leadership priorities and drive alignment throughout the organization.

“Medicine and healthcare delivery are transforming before our eyes, yet blood collection – essential to patient care – is largely stuck in old technology. By improving methods of blood collection, we can make big leaps forward in utilization rates of advanced therapies, for instance, improved adherence to routine

blood draws, and better patient care,” said Heenan. “It is my pleasure to join the YourBio board to help the company realize this valuable potential.”

Lane and Heenan join current board members including Martinez; YourBio Health President and CEO and Flagship Pioneering CEO-Partner, Paul Owen; founder and Managing Partner of Newpath Partners, Thomas Cahill; and Flagship Pioneering Senior Partner, Mark Stevenson.

About Wendy Lane

Wendy Lane is a highly experienced corporate director with more than 30 years of board service for major companies headquartered across the globe. Her expertise includes transformational change, crisis management, finance, M&A, compensation, human capital, audit, and corporate governance. Her generalist background enables her to bring new perspectives to technology, healthcare, life sciences, financial, and industrial companies. Her understanding of value creation enables companies to thrive, reach their full long-term potential, and maximize shareholder value. Prior to her career as an experienced board member, Wendy spent 15 years as an Investment Banker at DLJ and Goldman Sachs. She holds a BA from Wellesley College and an MBA from Harvard Business School.

About Christine Heenan

Christine Heenan is an Executive Partner, Executive Operations at Flagship Pioneering. She serves as a partner and advisor to the Flagship CEO on strategic areas and helps set leadership priorities and drive alignment throughout the organization. Christine joined Flagship in 2020 serving for five years as Chief Corporate Affairs Officer building and leading a corporate affairs function responsible for communications, government relations/regulatory affairs, digital and creative strategy, and brand and marketing across Flagship and its ecosystem companies.

Christine previously served as Senior Vice President for Global Policy and Advocacy at The Rockefeller Foundation and as Vice President of Public Affairs and Communications at Harvard University. She is the founder of Clarendon Group, a communications strategy and social impact consulting firm, and has advised clients including the Bill and Melinda Gates Foundation, the Whitehead Institute, the Ballmer Group, the Rockefeller Family Office, and other notable organizations, leaders, and philanthropists.

During the Clinton Administration, Christine served in the White House as a Senior Policy Analyst and speechwriter, focused primarily on health care policy, women’s issues, and other areas of domestic policy. She has taught at Brown University and Harvard College and served as a fellow at the Harvard Kennedy School’s Belfer Center and an executive fellow at Harvard Business School. She has directed or helped build award-winning podcasts and documentary films, and serves on the board of the David Rockefeller Fund, the John F. Kennedy Library Foundation, and Resilient Cities Catalyst.

About YourBio Health

YourBio Health is a medical device company that strives to take the pain out of the blood draw experience with its ‘Touch-Activated Phlebotomy’ (TAP®), the world’s first push button blood collection technology. TAP products eliminate barriers to blood collection by allowing a capillary blood sample to be collected from any physical location without the pain of a fingerstick or the need for traditional phlebotomy. Backed by the latest science, data management technology, and certified central labs,

YourBio Health seeks to revolutionize and humanize the blood collection process serving clinical, diagnostic, and reference laboratory applications. YourBio was founded by Flagship Pioneering in 2011.

Media Contact press@flagshippioneering.com